The ambitious ADAM project, a private initiative supported by CERN, will use ACCTs to measure the accelerated proton beam along the 3-GHz RF linac.
The beamline design is so compact that ACCT smaller sensors have to be developed.
ADAM is a new type of hadrontherapy accelerator with a very small footprint.
Its ambition is to fit in any hospital without major construction works.